LRP2 and cancer: ICIs are known to be influenced by the TME in inducing cancer cell death; an immunoactive "hot" microenvironment leads to a better response from the patient's anti-tumor immune system [43]. In this study, we found that LRP2-mutated patients had higher CR and PR rate and better prognosis after ICIs treatment.